Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.36 [1.16-1.58],0.00012448460258087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.85 [0.77-0.94],0.0014459276278507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NRP2,Neuropilin-2,Inverse variance weighted,11,0.73 [0.6-0.89],0.00211517118797555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.88 [0.81-0.96],0.00562004283103059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANXA10,Annexin A10,Wald ratio,1,4.47 [1.54-13.04],0.0060397972642948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.81 [0.69-0.94],0.00655395191420032,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.16 [1.04-1.3],0.0073523611097176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.1 [1.03-1.18],0.0074103171273459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GSN,Gelsolin,Inverse variance weighted,5,0.56 [0.36-0.86],0.00881075385486518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.15 [1.03-1.28],0.00945088742243879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.27 [1.06-1.52],0.0097753275816161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.24 [1.05-1.47],0.0105016977417864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,2.38 [1.22-4.63],0.01083339283447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.48 [0.28-0.85],0.0109412746621529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.81 [0.7-0.95],0.0109535577158819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.81 [0.69-0.95],0.01112366942061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,2.83 [1.24-6.49],0.0138695071503837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.65 [0.46-0.92],0.0153791939577204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.94 [0.89-0.99],0.0201496322596742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.83 [0.7-0.97],0.0218307701956065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.76 [1.09-2.85],0.0219115204629856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.2 [1.02-1.41],0.0264348548962859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.48 [1.04-2.12],0.0287380504026345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.92 [0.85-0.99],0.0309415119465954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,12,1.21 [1.02-1.44],0.0313451113999278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,1.26 [1.02-1.56],0.0331630922725295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL15,Interleukin-15,Wald ratio,1,289.67 [1.54-54369.73],0.0337991061505895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.91 [0.83-0.99],0.0354589200348626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.07 [1-1.14],0.035760372062393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.83 [0.69-0.99],0.0361622101345085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.1 [1.01-1.2],0.0370404295585643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.8 [0.64-0.99],0.0384193481439179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VGF,Neurosecretory protein VGF,Wald ratio,1,0.21 [0.05-0.93],0.0401876883602673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.22 [1.01-1.48],0.0434545398134183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.07 [1-1.14],0.0470884368373739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,6,0.77 [0.6-1],0.0498731227141199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.18 [1-1.4],0.0506803197837578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.84 [0.7-1],0.0525104386418465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.37 [0.13-1.02],0.0555435225097054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,1.25 [0.99-1.58],0.0573243908604142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.73 [0.53-1.01],0.0581729421259229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,0.87 [0.75-1],0.05847216445218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.93 [0.86-1],0.0613122527449908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.56 [0.31-1.03],0.0619687190965825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRTN3,Myeloblastin,Inverse variance weighted,21,0.9 [0.8-1.01],0.0622370617012657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.53 [0.27-1.03],0.0629909015468533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RSPO3,R-spondin-3,Inverse variance weighted,6,0.77 [0.58-1.02],0.0646270601398603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.06 [1-1.12],0.0648060862077654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.91 [0.82-1.01],0.0652950277204515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MFGE8,Lactadherin,Inverse variance weighted,11,0.86 [0.74-1.01],0.0656317088624599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,2.82 [0.93-8.53],0.0665672177146061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.62 [0.96-2.71],0.0687417144137193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OGN,Mimecan,Inverse variance weighted,30,0.89 [0.79-1.01],0.0702279844094456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.18 [0.99-1.42],0.0709417469058618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.31 [0.97-1.76],0.074423043345786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.38 [0.13-1.11],0.0759431862768445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.22 [0.98-1.52],0.0806710034262102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.18 [0.98-1.41],0.0829646217763033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.08 [0.99-1.18],0.0839162260024043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,0.95 [0.89-1.01],0.0861016770461356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.88 [0.76-1.02],0.0886971183444195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.42 [0.95-2.14],0.0899754615506213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS3,Galectin-3,Inverse variance weighted,25,0.91 [0.81-1.02],0.090048821253783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,0.88 [0.77-1.02],0.0919630093469477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.8 [0.62-1.04],0.0929449619433108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CX3CL1,Fractalkine,Inverse variance weighted,9,1.27 [0.96-1.69],0.0969266190339549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,2 [0.88-4.53],0.0980777953314541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD70,CD70 antigen,Inverse variance weighted,28,1.08 [0.99-1.18],0.0981635779334269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.68 [0.43-1.08],0.101760511413629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.67 [0.42-1.09],0.104062376015761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.74 [0.52-1.06],0.104731458496396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.68 [0.42-1.09],0.106831208229822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.8 [0.61-1.05],0.107736332193473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.36 [0.93-1.98],0.10851425572937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.82 [0.65-1.04],0.109100653651448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.65 [0.39-1.1],0.109427913953763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.09 [0.98-1.22],0.112024587256387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,1.23 [0.95-1.57],0.11256579019974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.81 [0.62-1.05],0.113762502396408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGRP,Agouti-related protein,Inverse variance weighted,3,1.59 [0.89-2.83],0.113885413670562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.08 [0.98-1.18],0.114905361782923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,UMOD,Uromodulin,Inverse variance weighted,29,1.06 [0.99-1.13],0.117959355018847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.65 [0.37-1.12],0.120091169410524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSD,Cathepsin D,Inverse variance weighted,17,1.15 [0.96-1.38],0.121758403758923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.67 [0.41-1.11],0.123965344261695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.84 [0.68-1.05],0.124334616776503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.89 [0.77-1.03],0.125589600528279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,1.08 [0.98-1.19],0.125621388391808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1.15 [0.96-1.39],0.126636699473039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINA11,Serpin A11,Inverse variance weighted,31,1.07 [0.98-1.16],0.12692138732608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.73 [0.48-1.1],0.127912976197637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.85 [0.69-1.05],0.130069308387699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,1.04 [0.99-1.09],0.131187329433826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.92 [0.83-1.03],0.134045128780294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK4,Kallikrein-4,Inverse variance weighted,17,0.92 [0.81-1.03],0.139192171887379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NFASC,Neurofascin,Inverse variance weighted,15,1.13 [0.96-1.32],0.139951976503262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEPTIN8,Septin-8,Inverse variance weighted,2,1.57 [0.86-2.87],0.140507639402955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,0.72 [0.47-1.12],0.142291923212402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.84 [0.66-1.06],0.144233367044761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,0.91 [0.81-1.03],0.147059707940163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DBI,Acyl-CoA-binding protein,Inverse variance weighted,9,0.84 [0.67-1.06],0.149538608760064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.15 [0.95-1.39],0.157804519186718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.81 [0.6-1.09],0.159928862712348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.95 [0.88-1.02],0.161987582355125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MDK,Midkine,Inverse variance weighted,4,1.29 [0.9-1.85],0.168119284823251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.79 [0.57-1.1],0.168724203935633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,0.83 [0.64-1.08],0.169078598018205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.87 [0.71-1.07],0.176029464457438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.89 [0.75-1.05],0.176946468487403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.17 [0.93-1.47],0.177572787389559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.92 [0.82-1.04],0.177765524769995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,F3,Tissue factor,Inverse variance weighted,11,1.15 [0.94-1.41],0.178776647910438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.66 [0.36-1.21],0.18156045210704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.7 [0.42-1.18],0.182517572782951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.79 [0.56-1.12],0.182891601087873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.88 [0.74-1.06],0.183267862049293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.04 [0.98-1.11],0.183286220000229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TMSB10,Thymosin beta-10,Wald ratio,1,0.53 [0.21-1.35],0.184803580205195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.7 [0.42-1.18],0.185000507792344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.87 [0.71-1.07],0.185787185060978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,2.05 [0.69-6.05],0.193550837657735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.46 [0.14-1.49],0.194245424087697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.77 [0.51-1.15],0.195497545114179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,1.14 [0.93-1.39],0.196038787864433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.91 [0.78-1.05],0.20018929563069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS4,Galectin-4,Inverse variance weighted,4,1.27 [0.88-1.85],0.203014642552351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.73 [0.46-1.18],0.204373088922887,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH1,Cadherin-1,Wald ratio,1,2.14 [0.66-6.93],0.206353671117158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.13 [0.93-1.37],0.211222451418091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PSAP,Prosaposin,Inverse variance weighted,5,0.81 [0.58-1.13],0.21319392796954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,C7,Complement component C7,Inverse variance weighted,38,0.95 [0.89-1.03],0.213855968737929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.17 [0.91-1.5],0.216270653864758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK8,Kallikrein-8,Inverse variance weighted,12,0.91 [0.77-1.06],0.216642176248124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.9 [0.77-1.06],0.220086487390913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.08 [0.96-1.21],0.225173039530883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCN5,CCN family member 5,Inverse variance weighted,8,1.3 [0.85-2],0.225510137039456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRELP,Prolargin,Inverse variance weighted,9,1.11 [0.94-1.31],0.225676632520604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GRN,Progranulin,Inverse variance weighted,7,1.12 [0.93-1.34],0.226356572307928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.1 [0.94-1.28],0.235098337080121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.86 [0.66-1.11],0.236362741263644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RTBDN,Retbindin,Inverse variance weighted,3,0.83 [0.61-1.13],0.238555207169936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHGB,Secretogranin-1,Inverse variance weighted,27,0.95 [0.86-1.04],0.238743221530132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.86 [0.67-1.11],0.240857951688276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.89 [0.74-1.08],0.241119043917851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPPC,C-type natriuretic peptide,Wald ratio,1,0.46 [0.12-1.7],0.241383222846728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.9 [0.76-1.07],0.241656640530286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.05 [0.97-1.15],0.241908371228102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.93 [0.82-1.05],0.242101617227316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.21 [0.88-1.67],0.242258889541486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.1 [0.94-1.3],0.24258271553068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.91 [0.78-1.07],0.243424295028867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.28 [0.84-1.96],0.245141554795429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,24,1.07 [0.95-1.2],0.246997305124282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.62 [0.71-3.66],0.249158282496148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.9 [0.75-1.08],0.249170589119967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP3,Stromelysin-1,Inverse variance weighted,34,0.93 [0.83-1.05],0.250500333236696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.94 [0.84-1.05],0.25118679520449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1.04 [0.97-1.12],0.253998637744412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.07 [0.95-1.19],0.255334928698826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.94 [0.84-1.05],0.255551706823679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.1 [0.94-1.29],0.255859295676087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.87 [0.69-1.1],0.256088181807042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.92 [0.79-1.06],0.257082382015998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.27 [0.84-1.93],0.258235519695985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.1 [0.93-1.3],0.258460127794443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.78 [0.5-1.21],0.258936516339699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MSLN,Mesothelin,Inverse variance weighted,25,0.95 [0.87-1.04],0.259061209792983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.07 [0.95-1.22],0.261653174945692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.83 [0.59-1.15],0.263454295337143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.2 [0.87-1.64],0.265131534654096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.96 [0.89-1.03],0.265831864716149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.76 [0.46-1.24],0.267955511130419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.93 [0.82-1.06],0.268239504670709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.13 [0.91-1.41],0.269277664629195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.17 [0.89-1.54],0.269493421981003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.84 [0.61-1.15],0.272099374012785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1.06 [0.96-1.16],0.273763866993025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.83 [0.59-1.16],0.278640986450915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,1.09 [0.93-1.28],0.281410185944786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.82 [0.56-1.18],0.28255534826998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.74 [0.63-4.79],0.283892315477204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.08 [0.94-1.23],0.287423905578747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CST6,Cystatin-M,Inverse variance weighted,2,0.86 [0.66-1.13],0.289470403441831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.97 [0.91-1.03],0.289850117706576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.05 [0.96-1.14],0.291290254361703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.95 [0.87-1.04],0.291811623910914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.68 [0.34-1.39],0.293579772648535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.15 [0.88-1.49],0.302730104996806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.9 [0.74-1.1],0.309723062763013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.9 [0.73-1.11],0.309956278352185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,S100P,Protein S100-P,Inverse variance weighted,2,0.68 [0.32-1.44],0.309962311393244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.63 [0.25-1.55],0.312199875718102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,0.91 [0.76-1.09],0.31299777511994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.96 [0.9-1.04],0.322558132065494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH6,Cadherin-6,Inverse variance weighted,29,0.96 [0.88-1.04],0.323762553450571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.05 [0.95-1.17],0.323840512282998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,19,0.96 [0.87-1.05],0.325185269228929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.18 [0.84-1.66],0.327115360579532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.23 [0.81-1.86],0.327413612469979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.07 [0.93-1.23],0.330201450737024,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BSG,Basigin,Wald ratio,1,1.22 [0.82-1.81],0.331111207513387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,1.16 [0.86-1.56],0.331190375843251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.06 [0.95-1.18],0.331751236113856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,0.95 [0.85-1.06],0.332071400626978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.67 [0.3-1.5],0.332644467307936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.85 [0.62-1.18],0.334620716057924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.63 [0.6-4.42],0.336315078442336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.92-1.26],0.337640392494579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.92 [0.79-1.09],0.339287487436212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.06 [0.94-1.2],0.339836933349349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLIN3,Perilipin-3,Wald ratio,1,0.69 [0.33-1.47],0.341454440240082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,0.93 [0.79-1.09],0.342051196036274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.95 [0.86-1.05],0.342234214191897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,1.16 [0.85-1.59],0.342441674086528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.11 [0.89-1.39],0.342906517458561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD302,CD302 antigen,Inverse variance weighted,9,0.91 [0.76-1.1],0.344009387437932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.04 [0.96-1.13],0.344234163641591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.21 [0.82-1.77],0.344414505739009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.1 [0.9-1.35],0.347255453546364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.1 [0.9-1.36],0.347662109880943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.39 [0.69-2.8],0.349799945001227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1.03 [0.96-1.1],0.354097628456613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.07 [0.93-1.22],0.354381429975497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RSPO1,R-spondin-1,Inverse variance weighted,5,1.11 [0.89-1.39],0.354722573622356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.86 [0.61-1.19],0.35728913888996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.12 [0.88-1.42],0.357870561296757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.96 [0.88-1.05],0.359060351197954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.2 [0.82-1.76],0.359138608797617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSL,Cathepsin L1,Wald ratio,1,1.74 [0.53-5.72],0.360103839979745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,2.02 [0.45-9.2],0.360907183872807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.09 [0.91-1.31],0.362276683876417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.12 [0.87-1.44],0.364526991966093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.92 [0.77-1.1],0.365497181895329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.84 [0.59-1.22],0.367622379320064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCG3,Secretogranin-3,Inverse variance weighted,32,0.95 [0.84-1.07],0.368083405820761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.08 [0.92-1.26],0.371295853139278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OCLN,Occludin,Inverse variance weighted,2,0.83 [0.55-1.25],0.37165243041856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL10,Interleukin-10,Wald ratio,1,0.79 [0.46-1.33],0.372195745432639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.06 [0.93-1.21],0.37246774950664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.92 [0.76-1.11],0.373592745971294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.07 [0.93-1.23],0.374633661460206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.92 [0.77-1.1],0.375213438152337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.73 [0.36-1.47],0.375880153750123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PYY,Peptide YY,Inverse variance weighted,6,1.1 [0.89-1.37],0.378707810063166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.03 [0.97-1.09],0.37926221969173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.06 [0.93-1.2],0.384168790874015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNC,Tenascin,Inverse variance weighted,12,0.9 [0.72-1.13],0.384484303696369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MENT,Protein MENT,Inverse variance weighted,3,1.06 [0.93-1.21],0.390383516604183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.93 [0.79-1.1],0.392682923751732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.95 [0.84-1.07],0.394624174964828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CWC15,Spliceosome-associated protein CWC15 homolog,Wald ratio,1,1.53 [0.57-4.13],0.398160391562348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.87 [0.62-1.21],0.405393090487441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.17 [0.8-1.7],0.408912368521811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL19,Interleukin-19,Inverse variance weighted,11,1.07 [0.91-1.26],0.412025537273059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DSC2,Desmocollin-2,Inverse variance weighted,9,1.08 [0.9-1.3],0.412687531351333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.06 [0.92-1.21],0.414896492332071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSO,Cathepsin O,Inverse variance weighted,6,1.11 [0.86-1.42],0.415216185115258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MB,Myoglobin,Wald ratio,1,1.83 [0.43-7.84],0.415977180614987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.28 [0.7-2.33],0.416044034844882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.07 [0.91-1.25],0.416706115440998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.96 [0.86-1.06],0.416801149084656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,1.04 [0.95-1.14],0.417885231429226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.04 [0.94-1.16],0.418936407384831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.95 [0.82-1.08],0.419164897521261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.15 [0.82-1.62],0.420084795186225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DPT,Dermatopontin,Inverse variance weighted,21,0.94 [0.81-1.09],0.421343903362929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.17 [0.8-1.73],0.422212619462398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.04 [0.94-1.15],0.422954411172461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [0.95-1.14],0.424281379983215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,STAB2,Stabilin-2,Inverse variance weighted,20,0.96 [0.86-1.06],0.425267251365893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MME,Neprilysin,Inverse variance weighted,3,1.31 [0.67-2.54],0.425722372658122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.13 [0.84-1.52],0.42808498579742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,THBD,Thrombomodulin,Inverse variance weighted,5,1.16 [0.8-1.67],0.429366000188656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGA2,Integrin alpha-2,Inverse variance weighted,31,1.04 [0.95-1.13],0.43464634793289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.6 [0.16-2.18],0.435178519780981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MVK,Mevalonate kinase,Inverse variance weighted,2,0.79 [0.44-1.43],0.4355834024147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.96 [0.87-1.06],0.437429738546641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.06 [0.92-1.22],0.440483832236864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.12 [0.84-1.49],0.442351109679964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PGF,Placenta growth factor,Inverse variance weighted,2,0.29 [0.01-7],0.444645114213253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.09 [0.88-1.34],0.445600069588164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.06 [0.91-1.23],0.446852087480578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,0.83 [0.51-1.35],0.447117860921775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.94 [0.8-1.1],0.44972709559909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.12 [0.84-1.49],0.454612525143466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.92 [0.74-1.14],0.455497057389226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NRP1,Neuropilin-1,Inverse variance weighted,12,1.06 [0.91-1.23],0.455818416599529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CNTN5,Contactin-5,Inverse variance weighted,28,1.03 [0.95-1.13],0.457425005284471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,APOA2,Apolipoprotein A-II,Wald ratio,1,0.73 [0.32-1.68],0.459815329347179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.19 [0.75-1.89],0.460217165873946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PKD2,Polycystin-2,Inverse variance weighted,3,0.73 [0.32-1.67],0.460284847194244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.94 [0.79-1.11],0.46052670635916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.07 [0.9-1.27],0.461754033203138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL4,C-C motif chemokine 4,Inverse variance weighted,18,0.93 [0.78-1.12],0.461769190039182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.93 [0.75-1.14],0.462150995746326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGRN,Agrin,Inverse variance weighted,17,0.94 [0.8-1.11],0.46245744117766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.03 [0.96-1.1],0.463270955330655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.97 [0.9-1.05],0.46478474534244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.27 [0.66-2.46],0.470372600704075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.5 [0.07-3.34],0.4706293503941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.84 [0.52-1.35],0.474172006363242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGMN,Legumain,Inverse variance weighted,12,0.95 [0.82-1.1],0.476509115791733,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS9,Galectin-9,Inverse variance weighted,26,1.05 [0.92-1.2],0.476881485613344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.94 [0.79-1.12],0.477689841178877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,1.32 [0.62-2.81],0.478210694448742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.07 [0.89-1.27],0.479073208262677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.09 [0.86-1.38],0.479328184608966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.93 [0.76-1.14],0.481082910591462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.86 [0.57-1.3],0.481373558431466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NECTIN4,Nectin-4,Inverse variance weighted,7,0.94 [0.8-1.11],0.484380016651614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.36 [0.57-3.23],0.484441833545923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.07 [0.89-1.28],0.48459243332567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.92 [0.74-1.15],0.487718756457354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,0.89 [0.64-1.24],0.488743097697649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.14 [0.79-1.63],0.489538127122912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.28 [0.64-2.55],0.489571494772284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.88 [0.62-1.26],0.492581822213031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1.03 [0.95-1.11],0.496611645086071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD83,CD83 antigen,Inverse variance weighted,5,0.91 [0.69-1.2],0.498608533583941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,1.03 [0.94-1.12],0.501296666810601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP6,Gastrotropin,Wald ratio,1,1.15 [0.76-1.74],0.501780081895725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.09 [0.85-1.38],0.502476371275149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPON2,Spondin-2,Inverse variance weighted,4,0.92 [0.73-1.17],0.503022025729115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.37 [0.54-3.5],0.504371534465054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VWF,von Willebrand factor,Inverse variance weighted,2,0.85 [0.53-1.37],0.506015693703872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.15 [0.77-1.71],0.506156343689036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,0.93 [0.76-1.14],0.507812349980675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP10,Stromelysin-2,Inverse variance weighted,22,0.95 [0.83-1.1],0.510401747873233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COLEC12,Collectin-12,Inverse variance weighted,11,0.92 [0.7-1.19],0.510909525373478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD160,CD160 antigen,Inverse variance weighted,11,1.05 [0.91-1.2],0.511423278078554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.86 [0.54-1.35],0.511568369678928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.65 [0.18-2.33],0.512642777134084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.08 [0.86-1.36],0.516090432496475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.57 [0.4-6.19],0.516114788209344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,1.05 [0.91-1.19],0.517424352354866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.09 [0.84-1.41],0.519616001067214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,0.92 [0.7-1.2],0.522772638348572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.1 [0.82-1.47],0.526083724614637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.5 [0.42-5.31],0.531684936402123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.04 [0.92-1.18],0.532238336295067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALB2,Calretinin,Wald ratio,1,0.75 [0.31-1.84],0.532255814319971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PVR,Poliovirus receptor,Inverse variance weighted,27,1.02 [0.95-1.1],0.533750180635165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.1 [0.82-1.47],0.534440747298132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.93 [0.74-1.17],0.535740460381708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.05 [0.9-1.23],0.537506923676101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.25 [0.61-2.59],0.538109610771887,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LCN15,Lipocalin-15,Inverse variance weighted,20,1.03 [0.93-1.14],0.540744059684472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPOCK1,Testican-1,Inverse variance weighted,6,0.91 [0.67-1.23],0.54429781485284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PENK,Proenkephalin-A,Inverse variance weighted,19,1.04 [0.91-1.2],0.546248699721367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.81 [0.42-1.59],0.546430086475433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.73 [0.27-2.02],0.54838117476037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRSS8,Prostasin,Inverse variance weighted,5,0.89 [0.61-1.31],0.549220723789621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1.37 [0.49-3.87],0.550496749996008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.79 [0.37-1.71],0.551500645954017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.93 [0.73-1.19],0.552462373838156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ASAH1,Acid ceramidase,Inverse variance weighted,20,0.97 [0.89-1.06],0.55357645892486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.97 [0.88-1.07],0.5549273594966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCN4,CCN family member 4,Inverse variance weighted,27,1.03 [0.93-1.14],0.556243511715038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC3B,Tetranectin,Inverse variance weighted,7,0.92 [0.7-1.22],0.560626480711611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.07 [0.85-1.36],0.561550955773306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.06 [0.88-1.26],0.562494659777095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,19,1.02 [0.95-1.11],0.562796697638261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,0.98 [0.9-1.06],0.563980088494061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL17C,Interleukin-17C,Inverse variance weighted,3,1.13 [0.75-1.68],0.565091954765896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ELN,Elastin,Inverse variance weighted,2,1.24 [0.6-2.56],0.565983446325367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCN3,CCN family member 3,Inverse variance weighted,19,1.05 [0.89-1.24],0.566024904747624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.05 [0.88-1.26],0.574523750010818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.08 [0.83-1.4],0.576319453650129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.98 [0.9-1.06],0.576964827793261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.9 [0.61-1.32],0.578098328989486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.9 [0.61-1.32],0.579437074468246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.08 [0.82-1.41],0.57991275229174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.96 [0.84-1.11],0.583855705383211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.69 [0.19-2.57],0.584541809827227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.18 [0.65-2.16],0.587531988449562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.93 [0.71-1.21],0.588765509992301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.97 [0.88-1.07],0.58892901782425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.85 [0.46-1.55],0.589506273899634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.17 [0.65-2.11],0.591967246931881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,0.84 [0.44-1.6],0.593074637550146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.04 [0.9-1.19],0.593963659309871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,0.97 [0.89-1.07],0.599260735126322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.97 [0.85-1.1],0.600457455675319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.03 [0.91-1.18],0.6006816304125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [0.92-1.15],0.604129339253939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TCOF1,Treacle protein,Wald ratio,1,1.34 [0.44-4.06],0.604291901977595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,1.14 [0.69-1.87],0.604306390464877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.96 [0.8-1.14],0.604740891831183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINB8,Serpin B8,Inverse variance weighted,28,0.98 [0.92-1.05],0.605368175932181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.02 [0.94-1.11],0.605389321444779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.91 [0.62-1.32],0.605512977071575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.02 [0.94-1.11],0.608340338401175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.04 [0.9-1.19],0.608904420115273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.04 [0.91-1.18],0.609027125919149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.09 [0.78-1.51],0.612030371324522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COCH,Cochlin,Inverse variance weighted,17,1.02 [0.94-1.11],0.613928071307611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TPR,Nucleoprotein TPR,Wald ratio,1,1.25 [0.53-2.94],0.616060076705969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.94 [0.73-1.21],0.617954459159361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD46,Membrane cofactor protein,Wald ratio,1,0.86 [0.46-1.58],0.618008524205593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.72 [0.2-2.61],0.621517038739468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.26 [0.5-3.19],0.621607512077545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,0.99 [0.93-1.04],0.621848395193338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.03 [0.91-1.16],0.624802588368387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.98 [0.88-1.08],0.624988717286863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IFNL1,Interferon lambda-1,Wald ratio,1,0.73 [0.21-2.57],0.626459308822009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.97 [0.84-1.11],0.627574957657096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.02 [0.95-1.1],0.631926854639622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.03 [0.92-1.14],0.631929653232338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.98 [0.88-1.08],0.63309977393414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,1.01 [0.96-1.07],0.633362123157555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.98 [0.89-1.07],0.633733606126948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.97 [0.86-1.09],0.63622020937066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.92 [0.64-1.32],0.639397947882975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.05 [0.84-1.32],0.641977464527442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.96 [0.79-1.16],0.643449800099346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.03 [0.91-1.16],0.64448001197301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.09 [0.76-1.55],0.644795949522837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPO,Erythropoietin,Inverse variance weighted,5,0.86 [0.46-1.63],0.645584217124806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK11,Kallikrein-11,Inverse variance weighted,6,1.04 [0.88-1.22],0.645899232587759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RBP2,Retinol-binding protein 2,Wald ratio,1,1.23 [0.5-3.04],0.646794462877514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.04 [0.87-1.25],0.650686719364725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.07 [0.8-1.43],0.652119537514604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.05 [0.86-1.28],0.65743315188896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAYN,Layilin,Inverse variance weighted,20,1.04 [0.88-1.21],0.657829998484769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.14 [0.64-2.04],0.65958382959837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.89 [0.53-1.49],0.660844178703089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BCAN,Brevican core protein,Inverse variance weighted,3,0.9 [0.55-1.47],0.661772340262146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD48,CD48 antigen,Inverse variance weighted,18,0.98 [0.9-1.07],0.662460338591655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,1.03 [0.9-1.18],0.662537984482604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.09 [0.75-1.58],0.662821676454832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.07 [0.78-1.49],0.663577728283741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.08 [0.77-1.52],0.665104139359136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALB1,Calbindin,Inverse variance weighted,2,1.15 [0.61-2.18],0.666482466106351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.96 [0.78-1.18],0.667724541020963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.07 [0.8-1.43],0.667860409531188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.02 [0.92-1.14],0.668016945378385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,0.96 [0.81-1.14],0.668709046763358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.03 [0.9-1.18],0.669960828152937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.03 [0.91-1.16],0.673852702578147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.12 [0.67-1.86],0.673861591119109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK13,Kallikrein-13,Inverse variance weighted,11,1.03 [0.89-1.19],0.675794274486432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SDC4,Syndecan-4,Inverse variance weighted,8,0.93 [0.68-1.29],0.678493955624453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.71 [0.15-3.52],0.678955797356945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.99 [0.93-1.05],0.680004735275299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.98 [0.89-1.08],0.681022235976855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.11 [0.68-1.82],0.681756617039586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RETN,Resistin,Inverse variance weighted,9,0.97 [0.85-1.11],0.682830559801387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.03 [0.9-1.17],0.68460154532177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,1.03 [0.89-1.19],0.684712560919019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.89 [0.51-1.55],0.687528467630828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.02 [0.92-1.13],0.690041782419425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.95 [0.73-1.24],0.695883248644922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.19 [0.5-2.84],0.701512518795099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REN,Renin,Inverse variance weighted,4,1.04 [0.85-1.27],0.706681531130259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.97 [0.81-1.15],0.707268871172039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.96 [0.79-1.17],0.708580288520945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.91 [0.57-1.47],0.710195400157817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.02 [0.92-1.12],0.711913369023315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.12 [0.61-2.05],0.718196789932597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,0.92 [0.58-1.46],0.718585255048147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.21 [0.43-3.35],0.719363390216445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.68 [0.08-5.63],0.7197104569289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.23 [0.39-3.87],0.720256193737977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CPM,Carboxypeptidase M,Inverse variance weighted,4,0.94 [0.67-1.31],0.722309679915753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1.05 [0.79-1.41],0.727511801650075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.89 [0.45-1.74],0.729489393733051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.91 [0.52-1.58],0.73173733992806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.08 [0.7-1.68],0.73179758868381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.12 [0.58-2.15],0.734763673350208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VWC2,Brorin,Inverse variance weighted,22,1.02 [0.89-1.17],0.735768485376976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,1.1 [0.62-1.95],0.737766915120542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.91 [0.52-1.59],0.738989729932259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.06 [0.74-1.52],0.741010387296587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.98 [0.86-1.12],0.741445455361484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SDC1,Syndecan-1,Inverse variance weighted,2,1.07 [0.72-1.58],0.743114911653193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRH,Corticoliberin,Inverse variance weighted,11,1.02 [0.89-1.17],0.743439749537308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCDH7,Protocadherin-7,Inverse variance weighted,3,0.93 [0.6-1.44],0.744635572368721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DSG2,Desmoglein-2,Inverse variance weighted,11,1.03 [0.86-1.23],0.744748502990725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.03 [0.84-1.27],0.745524813657621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.95 [0.71-1.28],0.745628565673667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.07 [0.72-1.59],0.746698874546007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP7,Matrilysin,Inverse variance weighted,13,1.02 [0.88-1.19],0.75105747579456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRSS2,Trypsin-2,Inverse variance weighted,3,1.06 [0.75-1.5],0.752322994163408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.02 [0.92-1.12],0.752604999634981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.11 [0.59-2.08],0.756135868279338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,0.91 [0.49-1.69],0.758949572075425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.68-1.68],0.761183632229903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.02 [0.88-1.19],0.761381059739839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.96 [0.75-1.24],0.762039562272675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.02 [0.91-1.14],0.762605038430172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.96 [0.73-1.26],0.764192292853829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,10,1.06 [0.74-1.5],0.765956740179989,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.97 [0.78-1.2],0.766064081314147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.98 [0.87-1.11],0.768318324614871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.14 [0.48-2.69],0.768817660289116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGA5,Integrin alpha-5,Wald ratio,1,0.87 [0.35-2.19],0.769222301721658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.97 [0.76-1.22],0.769882396487666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,0.97 [0.82-1.16],0.77026610997762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPR15L,Protein GPR15L,Inverse variance weighted,9,0.97 [0.82-1.16],0.771852012805076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.98 [0.88-1.1],0.773021541267078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.03 [0.83-1.28],0.773051049791537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.97 [0.79-1.19],0.775291478703357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.96 [0.71-1.29],0.776437838350514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AREG,Amphiregulin,Inverse variance weighted,3,1.05 [0.74-1.5],0.777110767546263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,1.17 [0.39-3.48],0.777843379162895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.02 [0.91-1.14],0.778509823466338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CST7,Cystatin-F,Inverse variance weighted,39,0.99 [0.91-1.07],0.778759333128211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ALCAM,CD166 antigen,Inverse variance weighted,6,0.95 [0.68-1.34],0.779136671378353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.9 [0.42-1.92],0.779449107629215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCG2,Secretogranin-2,Wald ratio,1,0.85 [0.27-2.7],0.780549151861644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.13 [0.46-2.78],0.781802307447458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.95 [0.66-1.37],0.781838558771362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.95 [0.64-1.4],0.785602038214553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,0.91 [0.44-1.85],0.787938823953146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FBLN2,Fibulin-2,Inverse variance weighted,11,0.98 [0.85-1.13],0.791005694328378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GUCA2A,Guanylin,Inverse variance weighted,9,0.97 [0.76-1.23],0.792315138618321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,0.98 [0.82-1.16],0.79516278640525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.94 [0.56-1.57],0.803216160239545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.05 [0.73-1.5],0.803840568684394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.84-1.25],0.805761523727507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD276,CD276 antigen,Inverse variance weighted,20,1.01 [0.92-1.12],0.808105517395426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.9-1.09],0.810126517465311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.01 [0.93-1.1],0.811644416181562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSV,Cathepsin L2,Inverse variance weighted,11,1.02 [0.84-1.25],0.811970896122347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.03 [0.79-1.36],0.812441615743565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.02 [0.85-1.23],0.819311415646388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1.02 [0.84-1.25],0.822641884344841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.99 [0.87-1.11],0.822689385609127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.96 [0.66-1.4],0.82367505348863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.04 [0.72-1.51],0.826254741434812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.93 [0.48-1.81],0.829637650545256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,1.03 [0.81-1.3],0.832852705571907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.94 [0.51-1.73],0.834571954077506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RGMB,RGM domain family member B,Inverse variance weighted,9,1.03 [0.81-1.29],0.834820145496218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.99 [0.86-1.13],0.83569146323009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LUZP2,Leucine zipper protein 2,Inverse variance weighted,8,1.03 [0.81-1.3],0.83589510562869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.85 [0.18-3.97],0.837175579719543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.97 [0.74-1.28],0.837277422116041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.9 [0.32-2.52],0.837651183982032,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH2,Cadherin-2,Inverse variance weighted,3,1.07 [0.56-2.05],0.83998283947049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,0.99 [0.9-1.09],0.840082987795576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MILR1,Allergin-1,Inverse variance weighted,33,0.99 [0.92-1.07],0.842913430234861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.03 [0.79-1.33],0.843169997583822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.96 [0.65-1.42],0.843609359089363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,1.03 [0.8-1.32],0.843853278816013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PALM2,Paralemmin-2,Inverse variance weighted,8,1.03 [0.78-1.35],0.845145228289896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.03 [0.78-1.36],0.846439449803937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.01 [0.94-1.08],0.84807254577164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPP1,Osteopontin,Inverse variance weighted,8,0.96 [0.66-1.4],0.850240116801411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.99 [0.85-1.14],0.850371314926652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1.01 [0.9-1.13],0.850567845305378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.02 [0.85-1.23],0.850642403106712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.01 [0.92-1.11],0.85611375648122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.99 [0.86-1.14],0.856853088985823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.94 [0.46-1.9],0.857668788727328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.99 [0.86-1.14],0.859518974390896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.99 [0.89-1.1],0.861137000587902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANXA5,Annexin A5,Inverse variance weighted,2,0.96 [0.57-1.6],0.862933179940442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,XCL1,Lymphotactin,Inverse variance weighted,31,0.99 [0.9-1.09],0.863402492288011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OSM,Oncostatin-M,Wald ratio,1,1.07 [0.49-2.34],0.863986515647541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPON1,Spondin-1,Inverse variance weighted,21,0.99 [0.85-1.14],0.864720570268765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.01 [0.92-1.11],0.864881681560263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.93-1.1],0.869950812843071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AMBP,Protein AMBP,Inverse variance weighted,3,0.97 [0.68-1.39],0.871557245787695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.01 [0.85-1.21],0.872848371635819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DRAXIN,Draxin,Inverse variance weighted,13,1.01 [0.9-1.13],0.873249763619028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.99 [0.83-1.17],0.874396147900503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.97 [0.65-1.45],0.874722580589378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.96 [0.61-1.51],0.876071047811417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1.03 [0.67-1.59],0.876152624767721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.94 [0.42-2.08],0.878259200005697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PI3,Elafin,Inverse variance weighted,10,0.99 [0.82-1.18],0.880032903255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.98 [0.73-1.32],0.880958963344406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.02 [0.78-1.33],0.881909938543945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.11 [0.27-4.64],0.882361234748514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.99 [0.91-1.09],0.88499567625796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.99 [0.93-1.07],0.885772540583807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.99 [0.9-1.1],0.885970203719272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.02 [0.79-1.31],0.886253341350349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,1.01 [0.87-1.18],0.887756444793362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.99 [0.87-1.13],0.888728242428034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.97 [0.6-1.57],0.889376057062417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LMNB2,Lamin-B2,Wald ratio,1,0.91 [0.24-3.48],0.890214975578627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.03 [0.69-1.54],0.891150565866469,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTN,Pleiotrophin,Inverse variance weighted,4,0.97 [0.59-1.58],0.891611916486554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1 [0.94-1.05],0.892656071531297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL18,Interleukin-18,Inverse variance weighted,16,1.02 [0.77-1.36],0.893445641073875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,1.07 [0.38-2.99],0.896287615067699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PALM,Paralemmin-1,Inverse variance weighted,6,1.02 [0.77-1.34],0.898043598328525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,3,0.98 [0.72-1.34],0.899504686873866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.01 [0.82-1.25],0.90157294635294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS1,Galectin-1,Inverse variance weighted,6,1.01 [0.86-1.19],0.904986997073172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,1.01 [0.92-1.09],0.906269068998673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.99 [0.79-1.23],0.910493177296947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.02 [0.74-1.4],0.913312955372678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.02 [0.77-1.35],0.913581985318341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HJV,Hemojuvelin,Wald ratio,1,0.98 [0.73-1.33],0.914466838272478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.09 [0.22-5.45],0.916535632154807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.98 [0.71-1.36],0.916657408797702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.01 [0.86-1.19],0.918322381357701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK6,Kallikrein-6,Inverse variance weighted,4,1.01 [0.77-1.33],0.919906479570495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.01 [0.9-1.13],0.921197321822537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PGA4,Pepsin A-4,Inverse variance weighted,2,1.03 [0.5-2.14],0.926278771730161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EDN1,Endothelin-1,Inverse variance weighted,3,0.99 [0.72-1.35],0.929072906940895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.01 [0.86-1.18],0.931982473481295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.96 [0.37-2.5],0.933165123549462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANG,Angiogenin,Inverse variance weighted,19,1 [0.9-1.13],0.933893205969629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALCA,Calcitonin,Inverse variance weighted,5,1.03 [0.57-1.85],0.933904658264115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH3,Cadherin-3,Inverse variance weighted,2,1.04 [0.4-2.68],0.93445483234745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.02 [0.69-1.49],0.937073329947475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.01 [0.71-1.46],0.938748363722382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.94 [0.19-4.76],0.939990227177246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.88-1.12],0.940327767659316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MUC13,Mucin-13,Inverse variance weighted,9,1.01 [0.78-1.3],0.950148686277707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1 [0.93-1.08],0.9505035673913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.87-1.16],0.951072743608623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.01 [0.71-1.44],0.951327966041339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.01 [0.79-1.28],0.952250737397298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.99 [0.69-1.43],0.954586464604153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.01 [0.68-1.51],0.955576999099792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.01 [0.64-1.6],0.957764274550744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.01 [0.62-1.66],0.957764274550744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CFD,Complement factor D,Inverse variance weighted,11,1 [0.84-1.19],0.958738057639592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,1 [0.83-1.19],0.95966635800173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.99 [0.81-1.22],0.959821685052521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.02 [0.46-2.29],0.960397841934064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.01 [0.62-1.66],0.962093637737251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NECTIN2,Nectin-2,Inverse variance weighted,5,1 [0.84-1.2],0.964175396695815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.96 [0.19-4.84],0.964179589905773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.99 [0.75-1.31],0.966441566874504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CST3,Cystatin-C,Inverse variance weighted,10,1 [0.84-1.2],0.968749760987878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1 [0.83-1.21],0.97054910554722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.01 [0.64-1.58],0.972030473066721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,1.02 [0.43-2.41],0.972777804237854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MATN2,Matrilin-2,Inverse variance weighted,18,1 [0.82-1.24],0.973023074913993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.99 [0.6-1.63],0.975106478308223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.85-1.17],0.976377364103462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,0.98 [0.29-3.29],0.977998317796217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHGA,Chromogranin-A,Inverse variance weighted,3,0.99 [0.69-1.44],0.978240738303813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,1.02 [0.27-3.87],0.979030445423307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFF3,Trefoil factor 3,Inverse variance weighted,5,1 [0.73-1.36],0.979604756718067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1 [0.7-1.42],0.982421952017281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,1 [0.89-1.12],0.98256794640783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1 [0.86-1.17],0.982767695037117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.01 [0.31-3.28],0.983947736120021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1 [0.65-1.56],0.985693359687933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1 [0.88-1.14],0.986555039431067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,1 [0.11-8.81],0.997008742472628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1 [0.56-1.78],0.997591456596648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VIT,Vitrin,Inverse variance weighted,25,1 [0.91-1.1],0.99983328338689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.51 [0.35-0.74],0.000477785945168509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PKD2,Polycystin-2,Inverse variance weighted,3,0.31 [0.15-0.64],0.00137954178807287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.08 [1.02-1.14],0.00412010002040402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.87 [0.79-0.96],0.00533732444057296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OGN,Mimecan,Inverse variance weighted,37,0.86 [0.76-0.96],0.00835383432650553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,4.64 [1.46-14.73],0.00931463098581792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.74 [0.59-0.93],0.00985442945990004,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.52 [1.08-2.13],0.0170584875006128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GSN,Gelsolin,Inverse variance weighted,7,0.63 [0.43-0.92],0.0176421395584855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK11,Kallikrein-11,Inverse variance weighted,13,1.4 [1.06-1.84],0.0179049491158231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRSS2,Trypsin-2,Inverse variance weighted,17,0.71 [0.53-0.95],0.0194118969972354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,2.6 [1.17-5.82],0.0196401587447165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.47 [1.06-2.05],0.0218218692891809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.65 [1.08-2.53],0.0218530273431358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.75 [0.58-0.96],0.0224180881489597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPO,Erythropoietin,Inverse variance weighted,11,0.78 [0.63-0.97],0.0227333720711456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MENT,Protein MENT,Inverse variance weighted,28,1.18 [1.02-1.36],0.0258170838376244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DBI,Acyl-CoA-binding protein,Wald ratio,1,2.3 [1.1-4.8],0.0266823783335956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RETN,Resistin,Inverse variance weighted,19,0.78 [0.62-0.98],0.0300256478207483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.57 [0.34-0.95],0.0302217519573594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.56 [0.33-0.95],0.0313585269359974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.24 [1.02-1.51],0.0317600218809525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.55 [1.04-2.3],0.0321157967904438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.65 [1.04-2.6],0.0322735006212716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,2.04 [1.06-3.93],0.0335501406175457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.8 [1.04-3.14],0.036562122908593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.79 [0.63-0.99],0.0404944259880118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CX3CL1,Fractalkine,Inverse variance weighted,12,1.44 [1.02-2.05],0.0410059171257065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.13 [1-1.26],0.0415164440593885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK6,Kallikrein-6,Inverse variance weighted,2,2.1 [1.01-4.36],0.0463935291258985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.53 [1-2.32],0.0491088806047365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.66 [0.44-1],0.0496345077807543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.7 [1-2.9],0.051764218813158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.89 [0.99-3.62],0.0528665964387319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.27 [1-1.63],0.0546153969012606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.51 [0.25-1.01],0.0546713062753504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCN3,CCN family member 3,Inverse variance weighted,17,1.18 [1-1.39],0.0550472047856177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP10,Stromelysin-2,Wald ratio,1,0.26 [0.07-1.05],0.0577434855956127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL6,Interleukin-6,Inverse variance weighted,6,0.8 [0.63-1.01],0.0601386370520201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,S100P,Protein S100-P,Inverse variance weighted,4,0.67 [0.44-1.02],0.0613253922777446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,F3,Tissue factor,Inverse variance weighted,13,1.37 [0.98-1.92],0.0619806817846013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.48 [0.98-2.23],0.0620003618393838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.45 [0.19-1.05],0.0637120243837148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.89 [0.79-1.01],0.0639002663011702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.3 [0.98-1.71],0.064157165176158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CST7,Cystatin-F,Inverse variance weighted,46,0.88 [0.77-1.01],0.0673190670074002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGA2,Integrin alpha-2,Inverse variance weighted,13,1.27 [0.98-1.65],0.0682139406272402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.9 [0.8-1.01],0.0709860131305977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DPT,Dermatopontin,Inverse variance weighted,4,0.54 [0.28-1.05],0.0710127119384334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.32 [0.97-1.78],0.073102524837751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.71 [0.48-1.03],0.0732863590686914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.56 [0.3-1.06],0.0734093741775801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.69 [0.46-1.04],0.0744695650989032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.13 [0.99-1.28],0.0757136710671509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.38 [0.13-1.11],0.0759431862768445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,0.27 [0.06-1.15],0.0760333185937707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OSM,Oncostatin-M,Inverse variance weighted,6,0.7 [0.48-1.04],0.0763336999604852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.16 [0.98-1.36],0.0774451055254913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP6,Gastrotropin,Inverse variance weighted,4,1.73 [0.94-3.19],0.0784227728027754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS3,Galectin-3,Inverse variance weighted,15,1.26 [0.97-1.64],0.0841638296852683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.81 [0.92-3.55],0.0853370113332762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD99,CD99 antigen,Inverse variance weighted,4,1.61 [0.94-2.76],0.0855907597812499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.63 [0.37-1.07],0.0872342176992798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.83 [0.67-1.03],0.0879251329067559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD302,CD302 antigen,Inverse variance weighted,11,0.8 [0.61-1.04],0.0891173016933447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GRN,Progranulin,Inverse variance weighted,46,1.08 [0.99-1.19],0.0893216441525505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK8,Kallikrein-8,Inverse variance weighted,5,0.63 [0.37-1.08],0.093535207990084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.28 [0.96-1.71],0.0935487887245284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.25 [0.96-1.61],0.0970986450028137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,2 [0.88-4.53],0.0980777953314541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.15 [0.97-1.36],0.0990912630388079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.46 [0.18-1.17],0.103587312043138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.43 [0.15-1.19],0.104112597859385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.78 [0.57-1.06],0.107311602847559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ALCAM,CD166 antigen,Inverse variance weighted,4,0.74 [0.52-1.07],0.108841718283274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALCA,Calcitonin,Inverse variance weighted,13,1.31 [0.94-1.83],0.111154236589263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.36 [0.93-1.99],0.114521897502195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.86 [0.71-1.04],0.114835906543291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.81 [0.63-1.05],0.115753657097928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,0.68 [0.41-1.1],0.116202418908191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.63 [0.35-1.13],0.118913090405351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.62 [0.33-1.13],0.11978951307166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PGF,Placenta growth factor,Inverse variance weighted,5,0.71 [0.46-1.1],0.120870452366128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.16 [0.96-1.41],0.120892018990698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.81 [0.62-1.06],0.123627609354158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPON2,Spondin-2,Inverse variance weighted,3,0.56 [0.27-1.17],0.124399487357154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.1 [0.97-1.25],0.12475390153077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.72 [0.47-1.1],0.126273032623847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.91 [0.83-4.39],0.126916767628178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PENK,Proenkephalin-A,Inverse variance weighted,15,1.19 [0.95-1.49],0.128124142712957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CST6,Cystatin-M,Inverse variance weighted,26,1.19 [0.95-1.5],0.131405233561723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.33 [0.92-1.93],0.131558722124789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRELP,Prolargin,Inverse variance weighted,5,0.58 [0.28-1.18],0.133553140469258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTN,Pleiotrophin,Inverse variance weighted,3,1.8 [0.83-3.88],0.134339196724766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,2.47 [0.75-8.14],0.137679545076979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.53 [0.23-1.23],0.138225510415847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.85 [0.82-4.21],0.140382593940265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.63 [0.85-3.1],0.140601621653354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRTN3,Myeloblastin,Inverse variance weighted,20,0.86 [0.7-1.05],0.141173833026329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.94 [0.86-1.02],0.142786515711848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.67 [0.39-1.15],0.144425182640818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,2.78 [0.7-11.04],0.144982438016771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.81 [0.6-1.08],0.150721785032749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,12,1.27 [0.92-1.77],0.150855883694929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.68 [0.4-1.15],0.151730167294634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.81 [0.61-1.08],0.155205736338944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.82 [0.62-1.08],0.155668634145469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.27 [0.91-1.76],0.156061919906752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,STAB2,Stabilin-2,Inverse variance weighted,14,0.8 [0.58-1.09],0.157100687055273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.18 [0.94-1.48],0.159351914385142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.82 [0.61-1.08],0.161645203311716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.17 [0.94-1.47],0.162264979926613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PSAP,Prosaposin,Inverse variance weighted,13,0.88 [0.74-1.05],0.166006343235178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.19 [0.93-1.52],0.167423280048032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.4 [0.87-2.26],0.168892782625833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1.22 [0.92-1.63],0.169770743982524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.61 [0.3-1.24],0.17138590738513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRH,Corticoliberin,Inverse variance weighted,55,1.09 [0.96-1.23],0.171897391393984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1.08 [0.97-1.21],0.175162192745947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.83 [0.64-1.09],0.180084798743127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,C7,Complement component C7,Inverse variance weighted,26,1.08 [0.97-1.2],0.181287930690371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCG3,Secretogranin-3,Inverse variance weighted,16,1.17 [0.93-1.46],0.183571855890126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.08 [0.96-1.22],0.185737363845348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.76 [0.51-1.14],0.186320007162113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.24 [0.9-1.72],0.190081050779333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.7 [0.41-1.2],0.190664523483274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD160,CD160 antigen,Inverse variance weighted,24,1.15 [0.93-1.41],0.191560493481103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCN5,CCN family member 5,Inverse variance weighted,12,0.88 [0.73-1.06],0.19465744449395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.31 [0.87-1.96],0.194800009477867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.89 [0.75-1.06],0.195694346720536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.33 [0.86-2.04],0.195758709709549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.22 [0.9-1.66],0.205682995976363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,0.64 [0.32-1.29],0.209128470850473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,0.79 [0.55-1.14],0.209962550532929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,2.09 [0.66-6.59],0.210123802653088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.66 [0.35-1.26],0.210408344271435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS4,Galectin-4,Inverse variance weighted,15,0.91 [0.78-1.06],0.210673663696759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.86 [0.68-1.09],0.215242607081912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,THBD,Thrombomodulin,Inverse variance weighted,11,1.13 [0.93-1.39],0.216664671918165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPOCK1,Testican-1,Inverse variance weighted,26,1.13 [0.93-1.39],0.21700070432653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.35 [0.07-1.85],0.218380666622045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.9 [0.77-1.06],0.21869243255484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.7 [0.4-1.24],0.222201352177525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.14 [0.92-1.41],0.222485619711181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.24 [0.88-1.75],0.225601694272446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.24 [0.87-1.76],0.227496119412578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.71 [0.41-1.24],0.234588694356313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.4 [0.8-2.46],0.238127736003294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.3 [0.84-2.01],0.240127472543228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,1.07 [0.95-1.21],0.24214550414455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.85 [0.65-1.12],0.243124717780822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Wald ratio,1,1.61 [0.72-3.58],0.243536419233981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MSLN,Mesothelin,Inverse variance weighted,11,1.2 [0.88-1.62],0.247723044374653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRSS8,Prostasin,Inverse variance weighted,14,1.23 [0.87-1.75],0.248989747324833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1.22 [0.87-1.72],0.249235975445646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.67 [0.33-1.33],0.250228451173521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.52 [0.17-1.59],0.253990511024494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,1.13 [0.92-1.38],0.256410907084854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.21 [0.87-1.7],0.259237134854107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.41 [0.77-2.57],0.260129679217359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCDH7,Protocadherin-7,Inverse variance weighted,3,0.68 [0.35-1.33],0.261383617899785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ELN,Elastin,Inverse variance weighted,10,1.31 [0.82-2.09],0.262807450902069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.53 [0.72-3.27],0.267348427355858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VWF,von Willebrand factor,Inverse variance weighted,6,1.3 [0.82-2.07],0.268973006315441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.93 [0.81-1.06],0.269432315523194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.12 [0.92-1.37],0.270405922016859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.86 [0.65-1.13],0.270971656081423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.3 [0.81-2.07],0.273523361594708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NECTIN2,Nectin-2,Inverse variance weighted,3,1.64 [0.67-4.01],0.273720078960682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,60,0.95 [0.87-1.04],0.273924170271745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VIT,Vitrin,Inverse variance weighted,10,1.18 [0.87-1.6],0.275446199053947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GCG,Pro-glucagon,Inverse variance weighted,2,0.5 [0.15-1.73],0.275598641461557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.07 [0.95-1.2],0.283244875262539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.17 [0.88-1.57],0.284627519362333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC3B,Tetranectin,Inverse variance weighted,2,1.72 [0.64-4.64],0.284661269383949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH2,Cadherin-2,Inverse variance weighted,21,0.89 [0.73-1.1],0.286574980887059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.73 [0.4-1.31],0.287565122075994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.12 [0.9-1.4],0.289906375262553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.31 [0.8-2.14],0.290093649611108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.83 [0.58-1.18],0.297787593293291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.93 [0.82-1.06],0.298018441435505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.8 [0.53-1.21],0.298985928419701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.89 [0.71-1.11],0.299145709151484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.37 [0.76-2.46],0.299239112528636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.06 [0.95-1.17],0.300415856258611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.21 [0.84-1.75],0.301757923781765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GUCA2A,Guanylin,Inverse variance weighted,7,0.83 [0.57-1.19],0.30390539125675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1.05 [0.96-1.15],0.306045991132346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.94 [0.82-1.06],0.309309534409782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TCOF1,Treacle protein,Wald ratio,1,1.94 [0.54-6.97],0.311541274740621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.63 [0.25-1.55],0.312199875718102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.84 [0.6-1.18],0.313635034476452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.13 [0.89-1.43],0.314535376807183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RSPO3,R-spondin-3,Inverse variance weighted,5,1.27 [0.8-2.03],0.314601925048959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.2 [0.84-1.73],0.31830100623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.41 [0.71-2.78],0.322979537693306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1.07 [0.94-1.21],0.323789880913425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCN4,CCN family member 4,Inverse variance weighted,29,1.06 [0.94-1.2],0.325196347187225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.23 [0.81-1.87],0.326574554818426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.17 [0.86-1.59],0.327328323200822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.13 [0.89-1.44],0.328236325201223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.41 [0.71-2.83],0.32829529738479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.86 [0.63-1.17],0.328837599749957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.2 [0.83-1.75],0.329092491324555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.87 [0.65-1.15],0.329839738926712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.74 [0.39-1.37],0.331660746728122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.41 [0.7-2.85],0.33305573101994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.13 [0.88-1.46],0.335473187771456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SDC1,Syndecan-1,Inverse variance weighted,12,1.14 [0.87-1.5],0.336252693328074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD48,CD48 antigen,Inverse variance weighted,14,1.16 [0.85-1.58],0.336374960482814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.82 [0.55-1.23],0.341299228151497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.08 [0.92-1.25],0.342964125631046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.81 [0.52-1.25],0.342986760520178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.82 [0.54-1.24],0.344479497616495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.2 [0.82-1.77],0.34546946515415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.47 [0.66-3.3],0.345694299511297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MDK,Midkine,Inverse variance weighted,14,1.15 [0.86-1.53],0.348203073990008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.83 [0.57-1.22],0.349952407510179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGMN,Legumain,Inverse variance weighted,22,1.14 [0.86-1.51],0.353907292754445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.09 [0.91-1.31],0.354037681204449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.95 [0.85-1.06],0.35726021012179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.22 [0.8-1.88],0.35745696807501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MVK,Mevalonate kinase,Wald ratio,1,3.83 [0.22-67.29],0.357832386891666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.06 [0.93-1.21],0.364618724643142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.97 [0.9-1.04],0.365052819961429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.2 [0.81-1.77],0.36697829453353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,0.89 [0.7-1.14],0.369069034510216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.1 [0.89-1.37],0.370557241977957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,0.91 [0.75-1.11],0.371723568690564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.67 [0.27-1.63],0.372840989671595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.29 [0.73-2.27],0.378318472697704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,0.6 [0.19-1.88],0.379430340932024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.13 [0.86-1.49],0.37976665311864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.89 [0.7-1.15],0.379819943370089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PVR,Poliovirus receptor,Inverse variance weighted,3,0.71 [0.33-1.53],0.380966652051127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFDC1,WAP four-disulfide core domain protein 1,Wald ratio,1,1.83 [0.47-7.05],0.381414044587701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,1.11 [0.87-1.42],0.38144780350453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,0.91 [0.73-1.13],0.384634300322823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.05 [0.94-1.18],0.386505370222892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.68 [0.28-1.64],0.387534196672133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.93 [0.79-1.1],0.390378866076449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NRP1,Neuropilin-1,Inverse variance weighted,14,0.87 [0.64-1.19],0.394202033132003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.11 [0.88-1.39],0.394664312927789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CST3,Cystatin-C,Inverse variance weighted,3,1.38 [0.66-2.89],0.394761100621934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.11 [0.88-1.39],0.395206445715474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.37 [0.66-2.81],0.395476525967942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.07 [0.92-1.24],0.395556601757496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.34 [0.68-2.65],0.396592740966722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ASAH1,Acid ceramidase,Inverse variance weighted,4,0.8 [0.48-1.33],0.398154155750429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.83 [0.54-1.28],0.400148077204099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.73 [0.34-1.54],0.403002873491785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.68 [0.28-1.67],0.405209451131045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.84 [0.56-1.26],0.405286990496359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.67 [0.5-5.6],0.408190516521211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.97 [0.91-1.04],0.408776747237229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MFGE8,Lactadherin,Inverse variance weighted,15,1.13 [0.84-1.5],0.415810299060451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.13 [0.84-1.5],0.416022226210104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.16 [0.81-1.66],0.416128686175695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.12 [0.85-1.47],0.416833971713726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.18 [0.79-1.74],0.420199644823823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.47 [0.58-3.75],0.420633696532664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.95 [0.83-1.08],0.427691626633729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Wald ratio,1,0.28 [0.01-6.45],0.427786105830772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.88 [0.64-1.21],0.428025850841582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.93 [0.78-1.11],0.428302828537723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.3 [0.68-2.48],0.430793545095164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.11 [0.85-1.45],0.430898092604478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL10,Interleukin-10,Inverse variance weighted,4,0.91 [0.72-1.15],0.433019718496692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.23 [0.73-2.07],0.433489518483156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,0.93 [0.79-1.11],0.436140399931305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.1 [0.87-1.38],0.438292981426308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.16 [0.8-1.68],0.443508675058051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.85 [0.56-1.3],0.446604808943134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CFD,Complement factor D,Wald ratio,1,0.64 [0.2-2.02],0.446685433958127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PYY,Peptide YY,Inverse variance weighted,16,1.07 [0.9-1.27],0.447710383816294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.85 [0.55-1.3],0.447791461563873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.24 [0.71-2.17],0.449980072557874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,XCL1,Lymphotactin,Inverse variance weighted,15,1.13 [0.82-1.56],0.450354013895653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.11 [0.84-1.47],0.450947661527366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.9 [0.67-1.19],0.451152338299124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.95-1.12],0.453178317913404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.05 [0.93-1.18],0.454085568579804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.78 [0.41-1.49],0.454704684378672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.85 [0.57-1.29],0.45498321208875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FBLN2,Fibulin-2,Inverse variance weighted,6,0.8 [0.45-1.43],0.458710255884821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.86 [0.58-1.28],0.459648787610865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.86 [0.57-1.29],0.460279050416031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RGMB,RGM domain family member B,Inverse variance weighted,5,0.77 [0.38-1.54],0.460815505349877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.1 [0.85-1.42],0.462069246761608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PALM,Paralemmin-1,Inverse variance weighted,4,0.79 [0.43-1.47],0.464044699813608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AREG,Amphiregulin,Inverse variance weighted,5,1.26 [0.67-2.37],0.46545704329911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,0.87 [0.6-1.26],0.466975038427743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.74 [0.33-1.67],0.469249106393926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.12 [0.83-1.51],0.46983586335456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.67 [0.22-2],0.471785029048634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.83 [0.5-1.38],0.475740148574595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.05 [0.91-1.22],0.476897004554457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CNTN5,Contactin-5,Inverse variance weighted,22,1.07 [0.89-1.28],0.478274603940715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.2 [0.72-1.98],0.480819828118178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.19 [0.74-1.92],0.48200877257219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.12 [0.82-1.52],0.483896090829456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.97 [0.88-1.06],0.485091600574836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.74 [0.31-1.74],0.485691215972324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.04 [0.94-1.15],0.491597309423536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,0.91 [0.7-1.19],0.494360866834222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.87 [0.59-1.29],0.495232312657936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.18 [0.73-1.89],0.497940138736424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1.16 [0.75-1.81],0.500385958012642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.05 [0.91-1.22],0.503040410949249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.07 [0.88-1.29],0.504453669939074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CFC1,Cryptic protein,Inverse variance weighted,11,0.87 [0.57-1.32],0.504877836724567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.14 [0.77-1.7],0.508148145499378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,0.87 [0.58-1.31],0.508745746099341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.97 [0.88-1.07],0.511020303742575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,1.04 [0.93-1.15],0.511191276153699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.82 [0.45-1.49],0.515628790788689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.94 [0.8-1.12],0.51569432700548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.18 [0.71-1.97],0.515855370502343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.95 [0.82-1.11],0.516627791313768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAYN,Layilin,Inverse variance weighted,3,1.28 [0.6-2.73],0.517973766738809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.11 [0.8-1.55],0.522323259640079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.37 [0.02-7.96],0.522487399969352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANG,Angiogenin,Inverse variance weighted,8,0.85 [0.51-1.41],0.5233160128557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OCLN,Occludin,Inverse variance weighted,2,0.56 [0.09-3.33],0.525629583178117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.15 [0.74-1.81],0.531162575619328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.12 [0.79-1.57],0.531583604383482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.14 [0.76-1.72],0.533802829140662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.05 [0.9-1.24],0.536627958720058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.63 [0.35-7.64],0.537581391087159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.81 [0.41-1.6],0.540941574139998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WNT9A,Protein Wnt-9a,Wald ratio,1,0.62 [0.13-2.88],0.540969166979154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.67 [0.19-2.4],0.542331877276301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.9 [0.65-1.25],0.544226702811912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.11 [0.79-1.58],0.545596264468161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NECTIN4,Nectin-4,Inverse variance weighted,4,0.75 [0.29-1.92],0.54631006206465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCG2,Secretogranin-2,Inverse variance weighted,2,0.76 [0.31-1.85],0.548310320742641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.04 [0.91-1.19],0.54906827401819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.18 [0.68-2.06],0.549382160706547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,0.95 [0.8-1.13],0.549420134028534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.1 [0.81-1.48],0.549689954062205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.97 [0.88-1.07],0.549749708704381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEPTIN8,Septin-8,Inverse variance weighted,4,1.16 [0.71-1.92],0.550431745240044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.86 [0.51-1.43],0.553765157233908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH3,Cadherin-3,Inverse variance weighted,10,0.91 [0.66-1.25],0.555851983229386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.1 [0.79-1.53],0.556171195183449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VWC2,Brorin,Inverse variance weighted,12,0.9 [0.63-1.28],0.557718591143884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.84 [0.47-1.5],0.557826074096375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP3,Stromelysin-1,Inverse variance weighted,4,0.74 [0.27-2.01],0.558405567805355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.11 [0.77-1.6],0.558742974863181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.87 [0.53-1.41],0.561338960498675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.81 [0.39-1.67],0.562052884128778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.07 [0.85-1.34],0.562732527214343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.85 [0.48-1.49],0.563283484106511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.96 [0.83-1.11],0.564199927700281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RTBDN,Retbindin,Inverse variance weighted,2,1.35 [0.48-3.8],0.56425911620482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,0.96 [0.83-1.11],0.565613744457837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.04 [0.9-1.2],0.566184456988442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.81 [0.39-1.67],0.566371424521678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.48 [0.39-5.68],0.567219339464126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,7,1.08 [0.82-1.43],0.567743313732737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.94 [0.76-1.16],0.568686295113296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINB8,Serpin B8,Inverse variance weighted,29,0.98 [0.91-1.05],0.571127802868116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.88 [0.57-1.36],0.571673671056857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.92 [0.7-1.22],0.574167923419985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSD,Cathepsin D,Inverse variance weighted,7,1.19 [0.65-2.18],0.575873008426611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.94 [0.77-1.16],0.577176382171227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.61 [0.11-3.53],0.581674789295278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.34 [0.47-3.8],0.581831093019243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.86 [0.51-1.47],0.583835882906361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.95 [0.8-1.14],0.587161684997351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,0.96 [0.84-1.11],0.587999324746117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPP1,Osteopontin,Inverse variance weighted,13,1.1 [0.79-1.53],0.58807791141181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.9 [0.62-1.31],0.589296346300904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.9 [0.62-1.32],0.589882271625008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,0.94 [0.76-1.17],0.590163286375348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHGB,Secretogranin-1,Inverse variance weighted,7,0.91 [0.64-1.29],0.591418468178404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,F9,Coagulation factor IX,Inverse variance weighted,3,1.2 [0.61-2.39],0.59468915392736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.93 [0.71-1.22],0.595418662524634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.9 [0.6-1.34],0.595901124857961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.12 [0.73-1.73],0.59762674768566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.18 [0.64-2.18],0.599555657742121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PGA4,Pepsin A-4,Inverse variance weighted,7,1.12 [0.73-1.7],0.601852451340556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.87-1.08],0.602089773099874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.91 [0.63-1.31],0.602953673612456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALB1,Calbindin,Inverse variance weighted,9,0.92 [0.66-1.27],0.604942120926583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.07 [0.82-1.41],0.605803963841964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LCN15,Lipocalin-15,Inverse variance weighted,22,1.03 [0.93-1.14],0.607221359193653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.93 [0.69-1.24],0.608579587273005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.9 [0.6-1.35],0.612735679521418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1.04 [0.9-1.2],0.612841435893113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.03 [0.93-1.13],0.61319347140161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.11 [0.74-1.65],0.613639916081851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNC,Tenascin,Inverse variance weighted,57,1.02 [0.94-1.12],0.614452474848259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.1 [0.76-1.6],0.6193564773759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.07 [0.81-1.42],0.620083616212453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COLEC12,Collectin-12,Inverse variance weighted,3,0.82 [0.38-1.78],0.621740339041155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.9-1.07],0.623615239210081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSV,Cathepsin L2,Inverse variance weighted,34,1.04 [0.9-1.19],0.625422683370812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,POF1B,Protein POF1B,Inverse variance weighted,4,0.84 [0.41-1.71],0.626591839151842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.06 [0.83-1.36],0.626740437430235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP8,Neutrophil collagenase,Inverse variance weighted,10,0.94 [0.71-1.23],0.629872112413692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSS,Cathepsin S,Inverse variance weighted,7,0.9 [0.6-1.37],0.636356444832191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.39 [0.36-5.35],0.636446592847723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.14 [0.67-1.94],0.636743600851745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,1.4 [0.34-5.7],0.637940531425496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MMP7,Matrilysin,Wald ratio,1,0.89 [0.54-1.46],0.641112487076332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BCAN,Brevican core protein,Inverse variance weighted,12,1.08 [0.78-1.48],0.643500173423709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.96 [0.81-1.14],0.644251965775213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.02 [0.94-1.11],0.645683730767425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.19 [0.57-2.49],0.645735330309489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK13,Kallikrein-13,Inverse variance weighted,11,1.07 [0.81-1.4],0.648382216486492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.94 [0.73-1.22],0.652509623891645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.32 [0.4-4.35],0.652927491390191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.87 [0.46-1.62],0.655358129340081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.94 [0.73-1.22],0.655388815879607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.97 [0.84-1.11],0.65717035518466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.05 [0.85-1.3],0.658386789558544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.93 [0.66-1.3],0.658540920890862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.69-1.26],0.660187365301434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.91 [0.61-1.37],0.661416662409838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.77 [0.23-2.54],0.661845511027104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.92 [0.64-1.33],0.663675182697529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.92 [0.63-1.34],0.665006813083348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.21 [0.51-2.88],0.665085218545321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.93 [0.65-1.32],0.665550401698991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HJV,Hemojuvelin,Inverse variance weighted,2,1.23 [0.48-3.12],0.667284042403759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,1.2 [0.52-2.79],0.66788419993016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BSG,Basigin,Inverse variance weighted,6,0.9 [0.56-1.45],0.668414705834343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.13 [0.64-2.02],0.668461100446725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.7 [0.14-3.52],0.668877721013431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1.01 [0.95-1.09],0.671610262592783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MME,Neprilysin,Inverse variance weighted,46,1.02 [0.92-1.15],0.671840237144727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.24 [0.46-3.35],0.672226005811278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.95 [0.77-1.18],0.672966456580641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.03 [0.9-1.18],0.673003256862639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MATN2,Matrilin-2,Inverse variance weighted,28,1.02 [0.93-1.13],0.67420716989117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SDC4,Syndecan-4,Inverse variance weighted,35,1.04 [0.88-1.22],0.676506365355566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.79 [0.25-2.45],0.677488554343642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.95 [0.76-1.2],0.678003998977283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.96 [0.77-1.19],0.67956323065937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.86 [0.41-1.78],0.680563941870457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.84 [0.36-1.95],0.681576834170936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.03 [0.88-1.22],0.683176628001045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,0.95 [0.76-1.2],0.685339214292312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL18,Interleukin-18,Inverse variance weighted,26,0.97 [0.83-1.13],0.6857858360093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.77 [0.22-2.73],0.688096269092907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.88-1.22],0.691403136907174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.88 [0.46-1.66],0.692959656934295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.03 [0.89-1.19],0.697290302015751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.98 [0.91-1.07],0.69972073882984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,1.05 [0.82-1.33],0.700812117224672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.92-1.06],0.700859581833173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.04 [0.86-1.25],0.701670684460896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.04 [0.86-1.26],0.702143461118671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.03 [0.89-1.19],0.702482284904364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGRN,Agrin,Inverse variance weighted,14,0.95 [0.72-1.25],0.702680310241373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.98 [0.86-1.11],0.709144454071559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.91 [0.54-1.52],0.712043591466673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSL,Cathepsin L1,Inverse variance weighted,29,0.97 [0.81-1.16],0.713089897274526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.9 [0.5-1.61],0.714897078995829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COCH,Cochlin,Inverse variance weighted,21,1.06 [0.78-1.44],0.715276622176687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NFASC,Neurofascin,Inverse variance weighted,6,1.1 [0.65-1.85],0.718333186001147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.05 [0.81-1.35],0.720083710510137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,1.17 [0.49-2.77],0.72021003096548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.08 [0.7-1.68],0.722960318216554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DRAXIN,Draxin,Inverse variance weighted,25,1.04 [0.85-1.27],0.723843518594617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.02 [0.91-1.15],0.72541763071027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.96 [0.77-1.2],0.726032904733113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.94 [0.67-1.33],0.727291556583804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD70,CD70 antigen,Inverse variance weighted,11,1.04 [0.83-1.3],0.728384042351335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.92 [0.56-1.49],0.729441209404874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,1.13 [0.57-2.24],0.729480791607514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.92 [0.58-1.47],0.73023581366813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.67-1.33],0.731310077543455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PPL,Periplakin,Inverse variance weighted,2,0.88 [0.43-1.81],0.732069810147275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CSTB,Cystatin-B,Inverse variance weighted,23,0.98 [0.88-1.1],0.737163087494326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,1.04 [0.81-1.34],0.739654349978255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.12 [0.57-2.19],0.740066158134666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.1 [0.62-1.94],0.740685242792333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD276,CD276 antigen,Inverse variance weighted,24,0.97 [0.8-1.17],0.741578135673909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.88 [0.4-1.91],0.742317718501294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,0.96 [0.77-1.2],0.746421568407837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MILR1,Allergin-1,Inverse variance weighted,43,0.99 [0.92-1.06],0.746771597076189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.95 [0.71-1.27],0.747388819421845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.09 [0.64-1.86],0.747537664911344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.17 [0.44-3.14],0.748096081260364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL15,Interleukin-15,Inverse variance weighted,35,1.03 [0.86-1.24],0.748363917839084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.14 [0.51-2.53],0.748775217752394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.22 [0.36-4.2],0.750711616776055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.91 [0.49-1.67],0.750901991649566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.92 [0.55-1.54],0.752571597620444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH6,Cadherin-6,Inverse variance weighted,5,0.92 [0.53-1.58],0.7537740653637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.04 [0.81-1.33],0.755259978982005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,1.04 [0.8-1.35],0.756972836171009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.94 [0.66-1.36],0.757280401275861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.96 [0.76-1.22],0.75791226934286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.05 [0.77-1.44],0.758210090687478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.68-1.68],0.761183632229903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.95 [0.68-1.33],0.761828451330815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CDH1,Cadherin-1,Inverse variance weighted,16,0.97 [0.77-1.21],0.764265769434546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LUZP2,Leucine zipper protein 2,Wald ratio,1,1.23 [0.32-4.79],0.765898372787907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.93 [0.58-1.49],0.76625877916805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.03 [0.87-1.21],0.766285757775519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,1.06 [0.74-1.51],0.769135100152576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.96 [0.73-1.27],0.773010362863886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.09 [0.61-1.93],0.773730798747489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.94 [0.61-1.45],0.776708591729608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.05 [0.75-1.48],0.778703660927029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,1.1 [0.55-2.22],0.780849454035107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.95 [0.64-1.4],0.781620518532198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.97 [0.78-1.2],0.786230852198879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.96 [0.72-1.29],0.79187194510227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.05 [0.75-1.45],0.793515151047464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.1 [0.54-2.26],0.797117021428058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,4,1.07 [0.62-1.85],0.797712979527231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,S100G,Protein S100-G,Inverse variance weighted,4,0.91 [0.44-1.89],0.798132750851083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL19,Interleukin-19,Inverse variance weighted,10,1.02 [0.86-1.21],0.79858401493153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.91 [0.43-1.93],0.800323445772811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.91 [0.44-1.88],0.801863478070761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.9 [0.38-2.14],0.802920874240011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.96 [0.69-1.33],0.80340641925852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.17 [0.33-4.15],0.804288526420061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.1 [0.5-2.43],0.8044931270294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.05 [0.7-1.57],0.804735154017651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.03 [0.81-1.31],0.8084480701337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.99 [0.91-1.08],0.81141977857783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.98 [0.87-1.12],0.813353896028181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,0.96 [0.66-1.39],0.813457212649888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CTSO,Cathepsin O,Inverse variance weighted,19,1.02 [0.84-1.24],0.814085779166508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,0.96 [0.67-1.38],0.814241417352315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.98 [0.79-1.2],0.814365109663023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NRP2,Neuropilin-2,Inverse variance weighted,14,0.96 [0.66-1.39],0.81462369036819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.07 [0.62-1.84],0.815035273371374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.87 [0.26-2.91],0.81651424465266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.88 [0.28-2.71],0.818700757279544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.09 [0.54-2.2],0.820365081626899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.92 [0.43-1.96],0.822139898613917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.91 [0.41-2.04],0.822300678822344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.08 [0.56-2.07],0.825368350954332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.87 [0.24-3.1],0.83014297593315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.05 [0.67-1.63],0.831072556996743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.1 [0.46-2.59],0.831584144041965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,22,0.98 [0.83-1.16],0.833537524498515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1.01 [0.93-1.09],0.83381574627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EGLN1,Egl nine homolog 1,Wald ratio,1,1.15 [0.32-4.15],0.83604524108737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.12 [0.4-3.13],0.836253397446067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.93 [0.45-1.91],0.836953641228369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.02 [0.83-1.25],0.836970770891013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.97 [0.74-1.28],0.837277422116041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.98 [0.82-1.18],0.838771047803956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.04 [0.69-1.58],0.84325982971509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.82-1.18],0.845011037602098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,0.94 [0.5-1.76],0.848947456022414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.87 [0.21-3.66],0.853122065953954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.1 [0.38-3.21],0.85454471881627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.79-1.32],0.858707322273368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.13 [0.3-4.3],0.858763722493153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.99 [0.84-1.16],0.85897190529333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.03 [0.75-1.41],0.860524020405942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.99 [0.88-1.11],0.86207602338538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.02 [0.82-1.26],0.86402118015276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL4,C-C motif chemokine 4,Inverse variance weighted,37,1.01 [0.91-1.11],0.868740814356689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,1.09 [0.39-3.04],0.868822954851951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.05 [0.57-1.96],0.86939255048019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.97 [0.66-1.42],0.869862267646791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,BRK1,Protein BRICK1,Inverse variance weighted,10,1.03 [0.71-1.49],0.870128689235102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINA11,Serpin A11,Inverse variance weighted,14,0.97 [0.67-1.41],0.870633487952429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.02 [0.79-1.33],0.871894585253418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS9,Galectin-9,Inverse variance weighted,36,0.99 [0.87-1.12],0.872710417625874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.05 [0.55-2.03],0.874924156210183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.99 [0.91-1.09],0.874967374571153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1.07 [0.46-2.46],0.875385453203702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPR15L,Protein GPR15L,Inverse variance weighted,13,1.01 [0.86-1.19],0.875640527066139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,KLK4,Kallikrein-4,Inverse variance weighted,5,1.06 [0.53-2.1],0.875824288911148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.04 [0.67-1.6],0.877060700037633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.94 [0.42-2.08],0.879483714211559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,1.01 [0.9-1.13],0.880994157371585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CAPG,Macrophage-capping protein,Wald ratio,1,1.08 [0.39-3],0.882581344458831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.95 [0.48-1.88],0.882796015590755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.02 [0.74-1.43],0.88696172135227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.01 [0.89-1.15],0.887990601186335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.98 [0.72-1.33],0.889537883733642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.02 [0.79-1.31],0.88984107800228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.02 [0.79-1.31],0.889985274432112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.97 [0.58-1.6],0.891337248033405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.86 [0.1-7.49],0.892572859914967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.84-1.22],0.892639405468045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REN,Renin,Inverse variance weighted,8,0.97 [0.6-1.56],0.892647246804498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.93 [0.3-2.87],0.893947262921223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.03 [0.64-1.66],0.894558236562016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AMBP,Protein AMBP,Inverse variance weighted,5,1.03 [0.63-1.7],0.896386732264402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.98 [0.69-1.38],0.89781571438785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.04 [0.53-2.04],0.898506639489705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.98 [0.69-1.39],0.899201523193515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.97 [0.57-1.65],0.903561908238059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.97 [0.57-1.64],0.905774362903908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,XG,Glycoprotein Xg,Inverse variance weighted,2,1.11 [0.19-6.47],0.905978180731288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RSPO1,R-spondin-1,Inverse variance weighted,8,0.98 [0.67-1.42],0.906122226448406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,0.98 [0.76-1.28],0.90700810282613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,UMOD,Uromodulin,Inverse variance weighted,34,1.01 [0.84-1.21],0.908564949873584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.96 [0.5-1.86],0.909156576314433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.02 [0.72-1.45],0.910803242463024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD83,CD83 antigen,Inverse variance weighted,14,1.02 [0.74-1.4],0.911645177436836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PI3,Elafin,Inverse variance weighted,18,0.99 [0.85-1.15],0.9127869229055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AGRP,Agouti-related protein,Inverse variance weighted,16,0.99 [0.79-1.24],0.914451134590525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.99 [0.78-1.26],0.916570973157299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.99 [0.9-1.1],0.916804398873348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,0.99 [0.82-1.19],0.917608753483255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DSG2,Desmoglein-2,Inverse variance weighted,22,1.01 [0.86-1.19],0.917800054313856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1 [0.91-1.11],0.923416174478261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.01 [0.75-1.38],0.926899713996283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.02 [0.66-1.57],0.927184401262644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.98 [0.64-1.51],0.927856065164778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.01 [0.83-1.22],0.929107610025936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,0.98 [0.65-1.49],0.930319127206511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.01 [0.78-1.32],0.93090140754019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.98 [0.69-1.42],0.934157920927321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CA6,Carbonic anhydrase 6,Inverse variance weighted,21,0.99 [0.77-1.27],0.934637175488479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.99 [0.86-1.15],0.935360198130154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.05 [0.32-3.43],0.938952202565461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.05 [0.27-4.14],0.941734380623206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.99 [0.67-1.45],0.941905661958407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1 [0.89-1.13],0.943112459816212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.72-1.42],0.944109901826012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.99 [0.7-1.4],0.944360522611581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1 [0.87-1.14],0.948563522764133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.02 [0.56-1.85],0.951701560611233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.99 [0.68-1.43],0.952201310602749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,0.98 [0.59-1.64],0.953812260164664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.03 [0.35-3.06],0.954125922639888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,1.01 [0.72-1.41],0.958379264576795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.98 [0.43-2.25],0.960736491061673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.99 [0.7-1.4],0.961388772191556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.01 [0.61-1.68],0.961626963327856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CHGA,Chromogranin-A,Inverse variance weighted,5,1.01 [0.67-1.52],0.961964087689576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.01 [0.72-1.41],0.966104856398138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LMNB2,Lamin-B2,Inverse variance weighted,8,0.99 [0.66-1.49],0.971108210814606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,DCN,Decorin,Inverse variance weighted,2,1.02 [0.39-2.64],0.97253274490595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.01 [0.43-2.39],0.974417506135544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1 [0.87-1.15],0.974454942691045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD27,CD27 antigen,Inverse variance weighted,9,0.99 [0.66-1.5],0.974460023352634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.01 [0.67-1.51],0.975551620066761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL22,Interleukin-22,Inverse variance weighted,4,0.99 [0.51-1.93],0.977275350780745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MUC13,Mucin-13,Inverse variance weighted,3,0.99 [0.42-2.31],0.977890499323506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.98 [0.26-3.67],0.978316440104985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1 [0.76-1.31],0.978339877762142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1 [0.77-1.3],0.979244279133854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1 [0.85-1.18],0.983265493664716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1 [0.67-1.5],0.983427856231886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,IL17C,Interleukin-17C,Inverse variance weighted,5,1 [0.59-1.72],0.985539818836719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1 [0.82-1.21],0.987519183771521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.99 [0.21-4.56],0.987947129775616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.99 [0.37-2.66],0.988303214254514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1 [0.68-1.46],0.98935866222997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1 [0.74-1.36],0.989383999489886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1 [0.76-1.32],0.989772579419372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1 [0.69-1.45],0.992392780748626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1 [0.38-2.63],0.992790436680215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1 [0.68-1.47],0.992928660879341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,1 [0.62-1.62],0.994003063606522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,MB,Myoglobin,Inverse variance weighted,9,1 [0.7-1.43],0.994958802504976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1 [0.59-1.7],0.997069953555074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,FOLR2,Folate receptor beta,Inverse variance weighted,14,1 [0.67-1.49],0.998206478455518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1 [0.65-1.53],0.998207643159891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1 [0.77-1.31],0.998500347420493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1 [0.72-1.38],0.998516634367756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,SPON1,Spondin-1,Inverse variance weighted,4,1 [0.57-1.75],0.999892181146213,trans
